Inter Pharma PCL Statistics

Total Valuation

Inter Pharma PCL has a market cap or net worth of THB 1.99 billion. The enterprise value is 2.38 billion.

Market Cap	1.99B
Enterprise Value	2.38B

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Inter Pharma PCL has 605.34 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	605.34M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.76%
Owned by Institutions (%)	1.16%
Float	273.87M

Valuation Ratios

The trailing PE ratio is 173.97.

PE Ratio	173.97
Forward PE	n/a
PS Ratio	1.10
PB Ratio	1.03
P/TBV Ratio	1.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.36, with an EV/FCF ratio of -406.19.

EV / Earnings	208.70
EV / Sales	1.32
EV / EBITDA	21.36
EV / EBIT	57.36
EV / FCF	-406.19

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.19.

Current Ratio	2.03
Quick Ratio	1.25
Debt / Equity	0.19
Debt / EBITDA	3.54
Debt / FCF	-68.29
Interest Coverage	2.27

Financial Efficiency

Return on equity (ROE) is 0.67% and return on invested capital (ROIC) is 1.06%.

Return on Equity (ROE)	0.67%
Return on Assets (ROA)	0.91%
Return on Capital (ROIC)	1.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.61
Inventory Turnover	3.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.24% in the last 52 weeks. The beta is 0.57, so Inter Pharma PCL's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-41.24%
50-Day Moving Average	3.75
200-Day Moving Average	4.63
Relative Strength Index (RSI)	34.11
Average Volume (20 Days)	239,445

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Inter Pharma PCL had revenue of THB 1.81 billion and earned 11.41 million in profits. Earnings per share was 0.02.

Revenue	1.81B
Gross Profit	666.15M
Operating Income	43.06M
Pretax Income	22.57M
Net Income	11.41M
EBITDA	69.36M
EBIT	43.06M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 219.32 million in cash and 400.49 million in debt, giving a net cash position of -181.17 million or -0.30 per share.

Cash & Cash Equivalents	219.32M
Total Debt	400.49M
Net Cash	-181.17M
Net Cash Per Share	-0.30
Equity (Book Value)	2.14B
Book Value Per Share	3.18
Working Capital	498.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 188.74 million and capital expenditures -194.60 million, giving a free cash flow of -5.86 million.

Operating Cash Flow	188.74M
Capital Expenditures	-194.60M
Free Cash Flow	-5.86M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 36.87%, with operating and profit margins of 2.38% and 0.63%.

Gross Margin	36.87%
Operating Margin	2.38%
Pretax Margin	1.25%
Profit Margin	0.63%
EBITDA Margin	3.84%
EBIT Margin	2.38%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.65%.

Dividend Per Share	0.02
Dividend Yield	0.65%
Dividend Growth (YoY)	-68.58%
Years of Dividend Growth	1
Payout Ratio	113.70%
Buyback Yield	0.03%
Shareholder Yield	0.69%
Earnings Yield	0.57%
FCF Yield	-0.30%

Dividend Details

Stock Splits

The last stock split was on May 7, 2024. It was a forward split with a ratio of 1.625.

Last Split Date	May 7, 2024
Split Type	Forward
Split Ratio	1.625

Scores

Inter Pharma PCL has an Altman Z-Score of 3.14.

Altman Z-Score	3.14
Piotroski F-Score	n/a